Geode Capital Management’s Gain Therapeutics GANX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $523K | Buy |
290,462
+8,251
| +3% | +$14.9K | ﹤0.01% | 3538 |
|
|
2025
Q1 | $539K | Buy |
282,211
+14,790
| +6% | +$28.3K | ﹤0.01% | 3512 |
|
|
2024
Q4 | $578K | Sell |
267,421
-4,551
| -2% | -$9.83K | ﹤0.01% | 3558 |
|
|
2024
Q3 | $484K | Buy |
271,972
+88,236
| +48% | +$157K | ﹤0.01% | 3588 |
|
|
2024
Q2 | $235K | Buy |
183,736
+6,645
| +4% | +$8.51K | ﹤0.01% | 3857 |
|
|
2024
Q1 | $668K | Buy |
177,091
+25,615
| +17% | +$96.6K | ﹤0.01% | 3511 |
|
|
2023
Q4 | $495K | Hold |
151,476
| – | – | ﹤0.01% | 3614 |
|
|
2023
Q3 | $489K | Buy |
151,476
+12,755
| +9% | +$41.2K | ﹤0.01% | 3611 |
|
|
2023
Q2 | $621K | Buy |
138,721
+44,514
| +47% | +$199K | ﹤0.01% | 3560 |
|
|
2023
Q1 | $454K | Buy |
94,207
+4,093
| +5% | +$19.7K | ﹤0.01% | 3677 |
|
|
2022
Q4 | $282K | Buy |
90,114
+2,147
| +2% | +$6.72K | ﹤0.01% | 3922 |
|
|
2022
Q3 | $286K | Buy |
87,967
+62,149
| +241% | +$202K | ﹤0.01% | 4013 |
|
|
2022
Q2 | $92K | Buy |
25,818
+190
| +0.7% | +$677 | ﹤0.01% | 4623 |
|
|
2022
Q1 | $104K | Buy |
25,628
+5,572
| +28% | +$22.6K | ﹤0.01% | 4647 |
|
|
2021
Q4 | $107K | Buy |
+20,056
| New | +$107K | ﹤0.01% | 4708 |
|